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Inflammatory bowel diseases (IBD) are characterized by an intestinal fibrosis that 
may lead to stenosis and obstruction (Burke et al., 2007) and by disfuntions of gastro-
intestinal (GI) motility associated with altered functions of enteric nerves, interstitial 
cells of Cajal or smooth muscle (Vetuschi et al., 2006). In experimental model TGFβ1/
Smad3 signalling plays a major role in tissue fibrogenesis (Latella et al, 2009). Aim of 
this study was to evaluate the potential role of the TGFβ1/Smads pathway in intes-
tinal fibrosis and to explore the possible mechanisms by which fibrogenesis induces 
alterations of GI motility in patients affected by CD. Evaluation of TGFβ1, CTGF, col-
lagen I-III, Smad3/7, PDGF, C-Kit, α-SMA, and a neuronal cocktail expression and 
a morphometrical analysis were performed in human CD terminal ileum samples; 
human smooth muscle cells (HSMC) were cultured for morphofuncional and mRNA 
expression (RT-PCR). Histo-morphometrical evaluation of stenotic fragments showed 
a significantly increase of a) both intestinal fibrosis and inflammation; b) mucosa, 
submucosa and muscle layer thickness and c) expression of TGFβ1, CTGF, collagen 
I-III, Smad3, PDGF, C-Kit and α-SMA staining. HSMC obtained from stenotic tracts 
showed an increase of PDGF-β and collagen I-III types mRNA and an inhibition in 
contractile response to acetylcholine compared to pre-stenotic tracts. These data sup-
port the hypothesis that TGFβ1/Smads pathway play a central role in development 
and differentiation of intestinal mesenchymal cells in sustaining intestinal fibrosis in 
CD and could be responsible for alteration of GI motility.
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